Merck Long-Term Investments 2012-2026 | MRK

Merck long-term investments for the quarter ending March 31, 2026 were $1.117B, a 94.26% increase year-over-year.

  • Merck long-term investments for 2024 were $0.463B, a 83.73% increase from 2023.
  • Merck long-term investments for 2023 were $0.252B, a 75.17% decline from 2022.
  • Merck long-term investments for 2022 were $1.015B, a 174.32% increase from 2021.

Merck Long-Term Investments 2012-2026 | MRK

  • Merck long-term investments for 2024 were $0.463B, a 83.73% increase from 2023.
  • Merck long-term investments for 2023 were $0.252B, a 75.17% decline from 2022.
  • Merck long-term investments for 2022 were $1.015B, a 174.32% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B